Imidazole
CAS 288-32-4
Imidazole (CAS 288-32-4) is a pharmaceutical compound with 3 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 20000 nM | 13 | - |
| - | Potency | 17392.600000000002 nM | 4 | - |
| - | Kd | 4400000 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Imidazole used for in pharmaceutical contexts?
Imidazole (CAS 288-32-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Imidazole?
No adverse-event association or SIDER side-effect rows are rendered for Imidazole in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Imidazole also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Imidazole with EU status "prohibited".
What clinical phase is Imidazole in?
No phase 1-4 clinical development badge is rendered for Imidazole because the matched compound identifier rows do not contain a max-phase value.